Keywords
Fatores de risco
Unidades de terapia intensiva
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objetivo: Identificar os fatores de risco para a infecção por Clostridioides difficile (ICD) em pacientes adultos internados em unidades de terapia intensiva. Métodos: Revisão integrativa da literatura, realizada por meio de busca na base de dados PubMed, incluindo artigos que avaliaram os fatores de risco para ICD em pacientes hospitalizados em unidades de terapia intensiva. As palavras-chave utilizadas foram “Clostridioides difficile”, “risk factors” e “intensive care units”. Resultados: A busca resultou em 74 artigos, dos quais 23 foram pré-selecionados para leitura e análise. Destes, 11 foram excluídos de acordo com o objetivo e os critérios de inclusão, sendo finalmente 12 artigos incluídos. Considerações finais: Os fatores de risco para ICD incluem o uso de antibióticos de amplo espectro, hospitalização prolongada, permanência em unidades de terapia intensiva, doença grave, idade avançada, terapia imunossupressora, nutrição enteral, inibidores da bomba de prótons, presença de comorbidades e distúrbios metabólicos. O conhecimento desses fatores é imprescindível para a prevenção e o adequado manejo terapêutico dos pacientes hospitalizados, sobretudo em unidades de terapia intensiva.
References
ANTONELLI M, et al. Clostridioides difficile (formerly Clostridium difficile) infection in the critically ill: an expert statement. Intensive Care MedicineSpringer, 2020; 46(2): 5873.
BALSELLS E, et al. Global burden of Clostridium difficile infections: A systematic review and meta-analysis. Journal of Global Health, 2019; 9(1): 10407.
BLOT S, et al. Healthcare-associated infections in adult intensive care unit patients: Changes in epidemiology, diagnosis, prevention and contributions of new technologies. Intensive and Critical Care Nursing, 2022; 70: 103227.
BUDDLE JE e FAGAN RP. Pathogenicity and virulence of Clostridioides difficile. Virulence Taylor and Francis Ltd, 2023; 10(1): 2150452.
CHAPELA S, et al. Prevalencia de diarrea en pacientes adultos en terapia intensiva y su relación con las fórmulas enterales listas para utilizar. Revista de la Facultad de Ciencias Médicas de Córdoba, 2022; 79(3): 36975.
CUI Y, et al. Risk factors for Clostridioides difficile infection and colonization among patients admitted to an intensive care unit in Shanghai, China. BMC Infectious Diseases, 2019; 19(1): 961.
DEL VECCHIO LE, et al. Risk Factors, Diagnosis, and Management of Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease. Microorganisms, 2022; 10(7): 1315.
FEUERSTADT P, et al. Mortality, Health Care Use, and Costs of Clostridioides difficile Infections in Older Adults. Journal of the American Medical Directors Association, 2022; 23(10): 153.
HEIMANN SM, et al. Economic burden and cost-effective management of Clostridium difficile infections. Medecine et Maladies Infectieuses, 2018; 48(1): 23-29.
KAABIA NM, et al. Epidemiology of Clostridioides difficile infection at a tertiary care facility in Saudi Arabia. Saudi Medical Journal, 2024; 45(2): 188-193.
KARAOUI WR, et al. Incidence, outcome, and risk Incidence, outcome, and risk factors for recurrence of nosocomial Clostridioides difficile infection in adults: A prospective cohort study. Journal of Infection and Public Health, 2020; 13(4): 485–490.
KASSEM S, et al. Clinical outcomes of clostridioides difficile infection in the very elderly. Internal and Emergency Medicine, 2024; 19(4): 1041-1049.
KIM SM, et al. Impact of chronic kidney disease on clinical outcomes in diabetic patients undergoing percutaneous coronary intervention in the era of newer-generation drug-eluting stents. Korean Circulation Journal, 2017; 47(2): 312.
LEE JC, et al. Severe Clostridium difficile infections in intensive care units: Diverse clinical presentations. Journal of Microbiology, Immunology and Infection, 2021; 54(6): 1111–1117.
LESSA FC, et al. Burden of Clostridium difficile Infection in the United States. New England Journal of Medicine, 2015; 372(9): 825–834.
LI C, et al. Incidence and outbreak of healthcare-onset healthcare-associated Clostridioides difficile infections among intensive care patients in a large teaching hospital in China. Frontiers in Microbiology, 2018; 9: 566.
MADA PK e ALAM MU. Clostridioides difficile Infection. StatPearls Publishing, 2023.
MATTHAIOU DK, et al. Characteristics, risk factors and outcomes of Clostridium difficile infections in Greek Intensive Care Units. Intensive and Critical Care Nursing, 2019; 53: 73–78.
MENG X, et al. Antibiotic Resistances and Molecular Characteristics of Clostridioides difficile in ICUs in a Teaching Hospital From Central South China. Frontiers in Medicine, 2021; 8: 745383.
MI H, et al. Colonization of Toxigenic Clostridium difficile Among Intensive Care Unit Patients: A Multi-Centre Cross-Sectional Study. Frontiers in Cellular and Infection Microbiology, 2020; 10: 12.
MOREELS T, et al. Self-Management Interventions for Facilitating Life Participation for Persons with Kidney Failure A Systematic Review. Clinical Journal of the American Society of Nephrology, 2024; 19(2): 189–201.
TAY HL, et al. Risk factors and treatment outcomes of severe Clostridioides difficile infection in Singapore. Scientific Reports,2019; 9(1): 13440.
WANG D, et al. Risk factors and intestinal microbiota: Clostridioides difficile infection in patients receiving enteral nutrition at Intensive Care Units. Critical Care, 2020; 24(1): 426.
WORLEY J, et al. Genomic Determination of Relative Risks for Clostridioides difficile Infection from Asymptomatic Carriage in Intensive Care Unit Patients. Clinical Infectious Diseases, 2021; 73(7): 1727–1736.